LibidUp-PF

LibidUp-PF (also marketed as LibidUp-PE) is a marketed nutraceutical formulation developed by MMC Pharmaceuticals for the treatment of premature ejaculation (PE) and the enhancement of male sexual wellness. It is formulated as an oral sachet containing a combination of active ingredients, including L-tryptophan, myo-inositol, D-chiro-inositol, vitamin B6 (pyridoxine), L-arginine, grape seed extract, and safed musli (Chlorophytum borivilianum). The formulation is designed to address the multi-factorial nature of premature ejaculation by boosting stamina and vigor, improving blood flow, and regulating the ejaculatory cycle. Clinical studies have shown that LibidUp-PF/PE significantly increases intravaginal ejaculatory latency time (IELT), reduces post-ejaculatory refractory time (PERT), and elevates plasma serotonin levels, offering a safe and well-tolerated alternative to selective serotonin reuptake inhibitors (SSRIs).

Brand names

LibidUp-PELibidUp-PFLibidup PE Sachets

Other names

Libidup PE